Bio Diligence

Bio Diligence was founded in response to the key challenges that both investors and medical biotech companies face in an increasingly complex; fast-paced and highly competitive global industry.

We work with those investors and biotech companies who are actively seeking to reduce risk and improve their product commercialisation outcomes in the therapeutic areas of medical devices and in vitro diagnostics by providing an end to end commercialisation solution.

We specialise in investor technology due diligence, technology licensing and product commercialisation programs.